Dr. Reddy's Laboratories, incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 97945.46 Crore) operating in Pharmaceuticals sector.
Dr. Reddy's Laboratories key Products/Revenue Segments include Pharmaceuticals, Licence Fees, Other Operating Revenue, Spent Chemicals, Service Income and Scrap for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-06-2023, the company has reported a Consolidated Total Income of Rs 6931.90 Crore, up 7.41 % from last quarter Total Income of Rs 6453.70 Crore and up 13.88 % from last year same quarter Total Income of Rs 6086.80 Crore. Company has reported net profit after tax of Rs 1400.70 Crore in latest quarter.
Investment Rationale
Follow through moves post series of multiple anchor columns implies continuation of an underlying trend.
Promoters held 26.69 per cent stake in the company as of 30-Jun-2023, while FIIs owned 26.99 per cent, DIIs 21.98 per cent.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price